Richardcyoung.com

  • Home
  • Debbie Young
  • Jimmy Buffett
  • Key West
  • Your Survival Guy
  • How We Are Different
  • Paris
  • About Us
    • Foundation Principles
    • Contributors
  • Investing
    • You’ve Read The Last Issue of Intelligence Report, Now What?
  • The Swiss Way
  • My Rifles
  • Dividends and Compounding
  • Your Security
  • Dick Young
  • Dick’s R&B Top 100
  • Liberty & Freedom Map
  • Bank Credit & Money
  • Your Survival Guy’s Super States
  • NNT & Cholesterol
  • Your Health
  • Ron Paul
  • US Treasury Yield Curve: My Favorite Investor Tool
  • Anti-Gun Control
  • Anti-Digital Currency
  • Joel Salatin & Alfie Oakes
  • World Gold Mine Production
  • Fidelity & Wellington Since 1971
  • Hillsdale College
  • Babson College
  • Contact Us

Will New COVID Treatment Pill End Forced Vaccinations?

December 23, 2021 By The Editors

By Javidestock @ Shutterstock.com

Americans across the country are losing their jobs or access to their favorite shops and businesses thanks to draconian vaccine mandates handed down by politicians with little regard for science. Despite the many supplements that can help COVID sufferers, the FDA has chosen to push people to get vaccinated. Now the FDA has given an emergency use authorization to Pfizer’s new COVID-treatment drug, Paxlovid. Will the FDA’s acceptance of this new COVID treatment mean an end to forced vaccinations? Fox Business reports:

The Food and Drug Administration approved an emergency use authorization on Wednesday for Pfizer’s oral antiviral treatment drug against COVID-19, Paxlovid.

Under the emergency use authorization, the treatment is for oral use in adults and children 12 years or older who weigh at least 40 kilograms or about 88 pounds and who are at high risk for progressing to severe COVID-19.

However, availability of Paxlovid will be limited at first and the Department of Health and Human Services will begin allocating around 65,000 courses of treatment in the first week of January to all 50 states and territories, as well as government agencies and Health Resources and Services Administration-funded health centers.

According to the Department of Health and Human Services, the initial allocations were made on a pro rata basis, and are being delivered at no cost to state and territorial health departments.

For example, California will receive 6,180 courses, while Missouri, for example, will receive 980 during the first week of allocations.

The Department of Defense, Department of State, Immigration and Customs Enforcement, and the Indian Health Service will also receive allocations of the drug.

Two-hundred Health Resources and Services Administration-funded health centers will receive 9,750 courses of Paxlovid during the first week’s allocation, which will help the department’s focus on equity.

“State and territorial health departments will allocate product to dispensing sites across their jurisdictions, and the distributor will ship product directly to receiving sites, which include pharmacies, doctors’ offices, clinics, hospitals, urgent care centers, and local health departments,” the Department of Health and Human Services announcement states.

The department expects that the supply of Pfizer’s Paxlovid will increase, as an additional 200,000 courses are expected in January, and shipments will occur every two weeks.

Pfizer announced in November that it would supply the U.S. government with 10 million treatment courses of Paxlovid between 2021 and 2022.

According to the Food and Drug Administration, Paxlovid is only available through a prescription and should be taken as soon as possible following a diagnosis of COVID-19 and within five days of symptoms beginning.

“Today’s authorization introduces the first treatment for COVID-19 that is in the form of a pill that is taken orally — a major step forward in the fight against this global pandemic,” Patrizia Cavazzoni, M.D., director of the FDA’s Center for Drug Evaluation and Research, said in a statement. “This authorization provides a new tool to combat COVID-19 at a crucial time in the pandemic as new variants emerge and promises to make antiviral treatment more accessible to patients who are at high risk for progression to severe COVID-19.”

On our COVID-19 page, you can see where cases are occurring in America today.

Related Posts

  • Colleges to Require COVID Vaccinations for In Person Learning
  • COVID Deaths Unfortunate but Insignificant
  • Covid-19’s Hidden Hobbies
  • Dozens of Treatment Options for Viral Infections
  • Author
  • Recent Posts
The Editors
The Editors
The Editors
Latest posts by The Editors (see all)
  • Patriot Missile Shortages Loom While Russia Ramps Up Barrages - July 8, 2025
  • Trump Administration Moves to Curb Foreign Ownership of U.S. Farmland - July 8, 2025
  • Trump Announces Vietnam Trade Deal - July 2, 2025

Dick Young’s Must Reads

  • Victor Davis Hanson: How to Bust DC’s Stronghold
  • Your Cash Swept into Your Broker’s Bank Account!
  • My Key West Garden Office
  • BLOOD THINNERS: Is a Big Advance Imminent?
  • “I Need Preservation of Principal and Growth”
  • The Claremont Institute: Protecting the American Way of Life
  • The Breakfast of Champions
  • You’re Ready to “Make It a Good Month”
  • “An Epic Struggle Over the Definition of America”
  • Who Owns Your Assets?

Our Most Popular Posts

  • What Makes America Great
  • Can Elon Musk Break the Two Party System?
  • “People Will Die”
  • Your Survival Guy: “You Wouldn’t Have Liked It”
  • How Healthy Are Eggs?
  • Just Don’t Call It “Obliterated”
  • Warthog's Last Stand: Could A-10's Have An Anti-Drone Role?
  • Survival Guy: An All-Weather Balanced Portfolio
  • Sending Capitalists to the Gulag
  • We Finally Got on the Boat

Compensation was paid to utilize rankings. Click here to read full disclosure.

RSS Youngresearch.com

  • Your Survival Guy: “You Wouldn’t Have Liked It”
  • DOE Unveils Plan to Quadruple U.S. Nuclear Power by 2050
  • How China Weaponized Rare Earths to Shift U.S. Trade Policy
  • Trump Administration Moves to Curb Foreign Ownership of U.S. Farmland
  • We Finally Got on the Boat
  • Trump Flexes Tariff Power Ahead of August 1 Deadline
  • America Remained a Net Energy Exporter as Domestic Output Soars
  • Copper Prices Surge as Global Supplies Tighten
  • Happy Independence Day!
  • Survival Guy: An All-Weather Balanced Portfolio

RSS Yoursurvivalguy.com

  • Your Survival Guy: “You Wouldn’t Have Liked It”
  • ESG Doesn’t Stand Up to Scrutiny
  • How to Dock a Boat with Helm Master EX
  • We Finally Got on the Boat
  • The Big Beautiful Bill: Good, Bad, and Ugly
  • WARNING: Your Survival Guy and Gal in the Fog
  • Happy Independence Day!
  • Survival Guy: An All-Weather Balanced Portfolio
  • A Bazooka Fired at Private Equity
  • NYC, Crypto, ESG, the Haves and the Have-Yachts

US Treasury Yield Curve: My Favorite Investor Tool

My Key West Garden Office

Your Retirement Life: Traveling the Efficient Frontier

Live a Long Life

Your Survival Guy’s Mt. Rushmore of Investing Legends

“Then One Day the Grandfather was Gone”

Copyright © 2025 | Terms & Conditions | About Us | Dick Young | Archives